Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for SHTDF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SHTDF and 80,000+ other tickers.
See exactly how SHTDF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SHTDF and 80,000+ other tickers.
Sinopharm Group Co. Ltd., along with its affiliates, plays a significant role in the People's Republic of China's healthcare sector, primarily engaging in the wholesale and retail trade of pharmaceuticals, medical equipment, and health-related products. The company organizes its extensive operations across four distinct divisions. Its Pharmaceutical Distribution unit supplies a wide array of medicinal products to various clients, including hospitals, other distributors, retail pharmacies, and clinics. This segment also provides comprehensive distribution, logistics, and additional value-added…
Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF - Get Free Report) shares passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $2.42 and traded as low as $2.35. Sinopharm Group shares last traded at $2.35, with a volume of 0 shares traded. Sinopharm Group Price Performance The
Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF - Get Free Report)'s share price passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $2.53 and traded as high as $2.60. Sinopharm Group shares last traded at $2.4750, with a volume of 600 shares traded. Sinopharm Group Stock Performance